MacroGenics Ownership | Who Owns MacroGenics?


OverviewForecastRevenueFinancialsChartTranscripts

MacroGenics Ownership Summary


MacroGenics is owned by 81.69% institutional investors, 2.13% insiders, and 16.18% retail investors. Bellevue group is the largest institutional shareholder, holding 15.83% of MGNX shares. BB Biotech AG Ord is the top mutual fund, with 15.82% of its assets in MacroGenics shares.

MGNX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMacroGenics81.69%2.13%16.18%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bellevue group9.93M15.83%$32.27M
Armistice capital6.28M10.00%$20.40M
Blackrock5.40M8.67%$22.96M
Blackrock funding, inc. /de5.06M8.06%$16.44M
Vanguard group4.32M6.88%$14.03M
Wasatch advisors lp3.49M5.56%$11.34M
Frazier life sciences management3.01M4.83%$12.80M
Millennium management2.86M4.57%$9.31M
State street1.54M2.48%$6.56M
Geode capital management1.43M2.28%$4.66M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bellevue group9.93M0.62%$32.27M
Frazier life sciences management3.01M0.60%$12.80M
Armistice capital6.28M0.28%$20.40M
Rock springs capital management lp1.05M0.13%$3.42M
Kazazian asset management42.04K0.10%$136.62K
Gsa capital partners llp246.60K0.06%$801.00K
Wasatch advisors lp3.49M0.06%$11.34M
Vestal point capital, lp280.00K0.05%$910.00K
Tang capital management218.86K0.05%$711.28K
Oxford asset management llp27.41K0.05%$89.08K

Top Buyers

HolderShares% AssetsChange
Wasatch advisors lp3.49M0.06%952.69K
Schonfeld strategic advisors857.50K0.02%857.50K
Frazier life sciences management3.01M0.60%539.02K
Jacobs levy equity management418.89K0.01%270.87K
Morgan stanley472.24K0.00%260.29K

Top Sellers

HolderShares% AssetsChange
Avoro capital advisors---6.15M
State street1.54M0.00%-2.85M
T. rowe price investment management---2.77M
Ra capital management---2.08M
Hudson bay capital management lp---916.53K

New Positions

HolderShares% AssetsChangeValue
Cubist systematic strategies111.99K0.00%111.99K$363.98K
Bridgeway capital management104.00K0.01%104.00K$338.00K
Susquehanna fundamental investments89.13K0.00%89.13K$289.69K
Hap trading75.00K0.00%75.00K$15.00K
Alps advisors50.75K0.00%50.75K$164.94K

Sold Out

HolderChange
Financial gravity asset management-2.00
Nelson, van denburg & campbell wealth management group-13.00
Rothschild investment-20.00
Innealta capital-68.00
Capital advisors-81.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024120-8.40%51,256,584-7.97%811.04%575.56%35-23.91%
Sep 30, 2024130-15.03%55,695,757-8.38%880.94%54-32.50%46-
Jun 30, 2024152-10.59%60,787,295-6.23%97890450.81%80-16.67%45-8.16%
Mar 31, 202417020.57%64,823,0655.10%-0.00%9626.32%496.52%
Dec 31, 202314111.02%61,676,1166.40%991.13%7633.33%46-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
BB Biotech AG Ord9.93M15.82%-
Wasatch Ultra Growth2.42M3.85%782.62K
Vanguard US Total Market Shares ETF2.00M3.17%-
Vanguard Total Stock Mkt Idx Inv1.97M3.14%-
iShares Russell 2000 ETF1.62M2.57%-14.03K
Vanguard Institutional Extnd Mkt Idx Tr931.11K1.48%-
Wasatch Micro Cap773.76K1.23%-
Fidelity Small Cap Index616.08K0.98%-11.54K
State St Russell Sm/Mid Cp® Indx NL Cl C476.20K0.76%-
State St Russell Sm/Mid Cp® Indx SL Cl I476.20K0.75%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 15, 2025Smith Beth Ann VP, Controller & TreasurerSell$1.08K
Apr 04, 2024Peters Jeffrey Stuart Senior VP and General CounselSell$3.80K
Apr 04, 2024Peters Jeffrey Stuart Senior VP and General CounselSell$94.93K
Apr 04, 2024Peters Jeffrey Stuart Senior VP and General CounselSell$57.67K
Apr 04, 2024Peters Jeffrey Stuart Senior VP and General CounselSell$2.28K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2024 Q2-5
2024 Q1-11
2023 Q411

MGNX Ownership FAQ


Who Owns MacroGenics?

MacroGenics shareholders are primarily institutional investors at 81.69%, followed by 2.13% insiders and 16.18% retail investors. The average institutional ownership in MacroGenics's industry, Biotech Stocks , is 68.48%, which MacroGenics exceeds.

Who owns the most shares of MacroGenics?

MacroGenics’s largest shareholders are Bellevue group (9.93M shares, 15.83%), Armistice capital (6.28M shares, 10.00%), and Blackrock (5.4M shares, 8.67%). Together, they hold 34.50% of MacroGenics’s total shares outstanding.

Does Blackrock own MacroGenics?

Yes, BlackRock owns 8.67% of MacroGenics, totaling 5.4M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.96M$. In the last quarter, BlackRock decreased its holdings by -294K shares, a -5.17% change.

Who is MacroGenics’s biggest shareholder by percentage of total assets invested?

Bellevue group is MacroGenics’s biggest shareholder by percentage of total assets invested, with 0.62% of its assets in 9.93M MacroGenics shares, valued at 32.27M$.

Who is the top mutual fund holder of MacroGenics shares?

BB Biotech AG Ord is the top mutual fund holder of MacroGenics shares, with 15.82% of its total shares outstanding invested in 9.93M MacroGenics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools